Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
IBRX · against 173 other Healthcare companies of similar size
Ranked #167 of 174 · scores higher than 4% of peers · safety percentile 6
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)15 peers with a safety percentile of 0–9, including IBRX · Click a bar to see the companies
Mainly because of its debt / equity, which is weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | IBRX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 169 reported | Not reported | 0.34× | — | — | 33% |
| BetaLower is better · 175 reported | 0.03 | 0.56 | 89% | 33% | |
| Current ratioHigher is better · 165 reported | 5.72× | 2.48× | 79% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 10.1B EUR (≈$11.1B) | 99 | ||
| 4 | 9.0B USD | 98 | 51 | |
| 5 | 4.6B USD | 98 | 29 | |
| 163 | 4.7B USD | 9 | 42 | |
| 164 | 14.6B USD | 8 | 59 | |
| 165 | 5.1B USD | 7 | 54 | |
| 166 | 11.6B USD | 6 | 57 | |
| 167 | 8.8B USD | 6 | 31 | |
| 168 | 7.3B USD | 6 | 32 | |
| 169 | 14.5B USD | 5 | 30 | |
| 170 | 7.0B USD | 5 | 57 | |
| 171 | 4.6B USD | 3 | 61 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score